EUPRAXIA PHARMACEUTICALS INC. Investment Income, Interest
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Investment Income, Interest of $1.41 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-03-13
| Period end | Investment Income, Interest 12 month |
|---|---|
| 2025-12-31 | $1.41M 40-F · filed 2026-03-13 |
| 2024-12-31 | $1.16M 40-F · filed 2026-03-13 |
| 2023-12-31 | $862.97K 40-F · filed 2025-03-20 |
| 2022-12-31 | $431.80K 40-F · filed 2024-04-01 |